| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.92▲ | 1.91▲ | 1.90▲ | 1.89▲ | 1.74▲ |
| MA10 | 1.91▲ | 1.90▲ | 1.94▼ | 1.74▲ | 2.20▼ |
| MA20 | 1.90▲ | 1.94▼ | 1.95▼ | 1.67▲ | 2.27▼ |
| MA50 | 1.90▲ | 1.91▲ | 1.78▲ | 2.31▼ | 2.62▼ |
| MA100 | 1.94▼ | 1.76▲ | 1.68▲ | 2.27▼ | 2.92▼ |
| MA200 | 1.95▼ | 1.67▲ | 1.92▲ | 2.59▼ | 2.39▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.006▲ | -0.005▼ | -0.020▼ | 0.083▲ | -0.054▼ |
| RSI | 63.663▲ | 51.834▲ | 55.944▲ | 51.540▲ | 43.677▼ |
| STOCH | 100.000▲ | 54.353 | 34.900 | 71.050 | 13.341▼ |
| WILL %R | 0.000▲ | -35.484 | -48.718 | -23.077▲ | -75.410▼ |
| CCI | 106.383▲ | 31.111 | -50.228 | 103.979▲ | -57.016 |
|
Monday, March 02, 2026 07:50 AM
CRDF READ THE FULL CRDF RESEARCH REPORT 2025 Financial Results Cardiff (NASDAQ:CRDF) reported 2025 financial and operational results in a press release and Form 10-K filing with the SEC on February 24 ...
|
|
Tuesday, February 24, 2026 01:30 PM
As of December 31, 2025, Cardiff Oncology had approximately $58.3 million in cash, cash equivalents, and short-term investments. Based on its current operating and clinical plans and projected ...
|
|
Thursday, February 19, 2026 02:03 AM
Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/03/26 | 1.87 | 1.93 | 1.83 | 1.93 | 0 |
| 27/02/26 | 1.95 | 2.02 | 1.90 | 1.94 | 858,400 |
| 26/02/26 | 1.96 | 2.05 | 1.89 | 1.96 | 1,217,100 |
| 25/02/26 | 1.76 | 1.96 | 1.74 | 1.91 | 2,442,600 |
| 24/02/26 | 1.57 | 1.74 | 1.56 | 1.70 | 983,800 |
| 23/02/26 | 1.59 | 1.64 | 1.54 | 1.56 | 754,437 |
| 20/02/26 | 1.63 | 1.67 | 1.61 | 1.61 | 440,000 |
| 19/02/26 | 1.56 | 1.65 | 1.55 | 1.63 | 406,400 |
| 18/02/26 | 1.56 | 1.62 | 1.55 | 1.56 | 421,800 |
| 17/02/26 | 1.59 | 1.615 | 1.55 | 1.56 | 451,340 |
|
|
||||
|
|
||||
|
|